Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-15 Purchase |
2022-07-15 4:25 pm |
Gossamer Bio Inc. | GOSS | Christian Waage EVP, Tech Ops and Admin |
6,934 | $7.21 | $49,994 | 615,118 (Indirect Direct) |
View |
| 2022-07-15 Purchase |
2022-07-15 4:23 pm |
Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO |
13,869 | $7.21 | $99,995 | 120,157 (Indirect Direct) |
View |
| 2022-07-15 Purchase |
2022-07-15 4:21 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
138,696 | $7.21 | $999,998 | 3,760,790 (Indirect Direct) |
View |
| 2022-07-01 Sale |
2022-07-05 4:39 pm |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
8,808 | $8.248 | $72,648 | 80,234 (Direct) |
View |
| 2022-06-22 Sale |
2022-06-23 6:47 pm |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
1,778 | $6.88 | $12,233 | 212,436 (Indirect Direct) |
View |
| 2022-05-04 Sale |
2022-05-05 6:14 pm |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
1,262 | $7.2 | $9,086 | 89,042 (Direct) |
View |
| 2022-03-23 Sale |
2022-03-24 4:57 pm |
Gossamer Bio Inc. | GOSS | Christian Waage EVP, Tech Ops and Admin |
10,722 | $8.915 | $95,587 | 608,184 (Indirect Direct) |
View |
| 2022-03-23 Sale |
2022-03-24 4:55 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
19,035 | $8.915 | $169,697 | 3,622,094 (Indirect Direct) |
View |
| 2022-03-23 Sale |
2022-03-24 4:53 pm |
Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO |
10,722 | $8.915 | $95,587 | 106,288 (Indirect Direct) |
View |
| 2022-03-16 Sale |
2022-03-17 5:03 pm |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
5,002 | $8.278 | $41,407 | 90,304 (Direct) |
View |
| 2022-03-16 Sale |
2022-03-17 5:00 pm |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
6,279 | $8.278 | $51,978 | 66,172 (Direct) |
View |
| 2022-03-16 Sale |
2022-03-17 4:58 pm |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
6,278 | $8.279 | $51,976 | 214,214 (Indirect Direct) |
View |
| 2021-10-25 Sale |
2021-10-26 5:08 pm |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
2,377 | $12.25 | $29,118 | 72,451 (Direct) |
View |
| 2021-10-25 Sale |
2021-10-26 5:01 pm |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
2,377 | $12.25 | $29,118 | 95,306 (Direct) |
View |
| 2021-10-25 Sale |
2021-10-26 4:58 pm |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
2,377 | $12.25 | $29,118 | 219,971 (Indirect Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:13 pm |
Gossamer Bio Inc. | GOSS | Salter-Cid Luisa Chief Scientific Officer |
5,491 | $9.4795 | $52,052 | 206,065 (Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:11 pm |
Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer |
5,490 | $9.4801 | $52,046 | 117,010 (Indirect Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:09 pm |
Gossamer Bio Inc. | GOSS | Christian Waage EVP & General Counsel |
5,490 | $9.481 | $52,051 | 617,375 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-06 Option Award |
2022-01-10 4:13 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:11 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:09 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:07 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Christian Waage EVP & General Counsel |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:05 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO |
265,000 | $0 | 265,000 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:03 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
650,000 | $0 | 650,000 (Direct) |
View |
| 2021-09-16 Option Award |
2021-09-20 4:25 pm |
N/A 2031-09-16 |
Gossamer Bio Inc. | GOSS | Giraudo Bryan COO/CFO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:02 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
25,000 | $0 | 97,683 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 8:13 pm |
N/A 2031-06-21 |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
45,000 | $0 | 249,809 (Direct) |
View |
Ownership |
2021-06-22 8:10 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Aranda Richard Chief Medical Officer |
0 | $0 | 398,939 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:26 pm |
N/A 2031-06-09 |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 9:41 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | Bilenker Joshua H. Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 9:01 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | Burow Kristina Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 7:54 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | Daniel Thomas O Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 7:52 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | GALA RENEE D Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 7:49 pm |
N/A 2031-06-08 |
Gossamer Bio Inc. | GOSS | Cox Russell J. Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 5:15 pm |
N/A 2031-05-03 |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
42,570 | $0 | 104,433 (Direct) |
View |
Ownership |
2021-05-05 5:11 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Carter Laura Chief Scientific Officer |
0 | $0 | 248,038 (Direct) |
View |
| 2021-04-16 Option Award |
2021-04-20 6:07 pm |
N/A 2031-04-16 |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
42,570 | $0 | 106,578 (Direct) |
View |
Ownership |
2021-04-20 5:43 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
0 | $0 | 324,015 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 7:40 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
487,500 | $0 | 3,966,129 (Direct) |
View |